• 제목/요약/키워드: HANA

검색결과 512건 처리시간 0.033초

세계 수준의 연구전산망 뉴스 및 FTP서버 구축 관리

  • 서상용
    • 지식정보인프라
    • /
    • 통권4호
    • /
    • pp.36-41
    • /
    • 2001

  • 연구전산망은 1994년부터 뉴스서버 news.kreonet.re.kr을 가동하면서 지금은 사라진 하나망 뉴스서버 usenet.hana.nm.kr과 더불어 국내 양대중심(bacbone) 사이트 역할을 수행하였다.

  • PDF

위암 및 간암환자의 치료에 있어 양.한방 협진의 효과에 관한 임상시험 (Clinical Study of the Efficacy of Combined Western-Oriental Medicine for Gastric Cancer and Hepatocellular Carcinoma)

  • 이종인;심광용;김호영;최서영;방대건;조경숙
    • 대한한방종양학회지
    • /
    • 제7권1호
    • /
    • pp.117-129
    • /
    • 2001

  • Objectives: We compared the therapeutic response, the treatment-related toxicity, and the improvement of subjective symptoms between the chemotherapy alone group and the western-oriental combined treatment group and evaluated the role of oriental medicine for the improvement of chemotherapy-related toxicity in the advanced gastric cancer and hepatocellular carcinoma. Methods: We evaluated 36 gastric cancer or hepatocellular carcinoma patients(chemotherapy alone group 25 patients, combined treatment group 11 patients) who had been treated in Wonju Christian Hospital and Hana Hospital of Oriental Medicine between June 1999 and October 2000. Enrolled patients' general medical records, results of laboratory and imaging studies, treatment-related toxicities, and subjective symptoms were recorded regularly according to the planned protocol. Therapeutic responses were estimated according to the WHO response criteria and the changes of tumor marker value such as CEA, CA 72-4 and AFP. Results: 1. There was no significant difference of therapeutic response by the WHO response criteria between the two groups(p=.459). 2. There was a significant decrease of tumor marker value in the combined treatment group compared to the chemotherapy alone group(p=.023). 3. There was less comprehensive treatment-related toxicity in the combined treatment group compared to the chemotherapy alone group(p=.037), but there was not a significant difference of comprehensive improvement of subjective symptoms between the two groups(p=.091). Conclusions: Based on the above results, we could expect the possibility of improvements in therapeutic response and treatment-related toxicity with the western-oriental combined anticancer treatment.

  • PDF